You can buy or sell NanoString and other stocks, options, ETFs, and crypto commission-free!
NanoString Technologies, Inc. engages in the provision of life science tools for translational research and molecular diagnostic products. It offers analysis solutions, gene expression panels, protein assays, DNA Assaya, miRNA assays, vantage 3D assays, custom solutions, sample prep and nCounter consumables, and nDesign gateway. Read More The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.
52 Week High
52 Week Low
Seeking AlphaMar 19
NanoString prices 4.5M-share offering at $23
NanoString Technologies (NASDAQ:NSTG) has priced an offering of 4.5M shares at $23 each, Bloomberg reports, a 5.3% discount to today's close.
Markets InsiderMar 19
NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock
SEATTLE, March 19, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $23.00 per share pursuant to its shelf registration statement. NanoString will sell 2,500,000 shares of common stock, and Clarus Lifesciences II, L.P., a stockholder of NanoString, will sell 2,000,...
Expected May 8, After Hours